DEF 14AThe Ballot
Damora Therapeutics, Inc. files DEF 14A
Filed Apr 29, 2026 · 2mo ago · Accession 0001193125-26-191429
Plain English
Proxy statement — executive pay, board nominees, and shareholder votes.
Read the source below for the full document.
Filing details
- Company
- Damora Therapeutics, Inc.
- Ticker
- DMRA
- CIK
- 1800315
- Form type
- DEF 14A
- Filing date
- Apr 29, 2026
- Report date
- Apr 29, 2026
- Document
- dmra-20260429.htm
- Size
- 3.8 MB